A rapid new test for brain tumours is set to change everything for patients, slicing the time it takes for an accurate diagnosis from weeks to just two hours! Yes, you heard that right! This groundbreaking technology, currently being rolled out by the NHS, means that individuals can finally breathe a sigh of relief and get the treatment they need much quicker. Take Steve Palmer, for instance. The 55-year-old from Nottingham had his diagnosis while surgeons were still operating on him to remove the tumour. Can you imagine that? He was diagnosed with a grade 4 glioblastoma after collapsing at the gym, and thanks to this innovative test, he found out what he was up against almost immediately.
NHS England is piloting this genomic test in specialist centres across the country. The beauty of it lies in its speed; it analyzes the genetic code of a small sample taken from the tumour. Incredibly, there are about 150 different types of brain tumours, each responding differently to treatment. This new method allows doctors to tailor the best treatment for each specific case, which is a game-changer! Steve’s story is just one among thousands, as over 12,000 people in the UK are diagnosed with a primary brain tumour each year. That’s a staggering number, and the urgency for quick and accurate testing has never been more apparent.
The test works by sending small tissue samples to a pathology lab, where they are prepared for a shoebox-sized sequencing machine developed by Oxford Nanopore. This technology, in collaboration with the University of Nottingham, reveals the tumour’s unique genomic fingerprint. Dr. Smith, from Queens Medical Centre where Steve was operated on, described the results as “almost magical,” stating that diagnosing the tumour while the patient is still on the operating table can drastically change how surgeons proceed with the operation. They can be more cautious with aggressive tumours that are beyond surgical removal, aiming to reduce the risk of brain damage.
This rapid test not only provides quicker diagnoses but also means patients can access clinical trials sooner. It’s a win-win! Speaking to BBC Breakfast, Prof. Frankie Swords, NHS medical director, highlighted how this remarkable test could transform the landscape of brain tumour diagnosis, bringing results to patients in days instead of weeks. She referred to the pilot scheme as a “world first,” emphasizing that no other health service has anything quite like it.
Currently, the pilot is underway in Nottingham and Birmingham, with plans to expand to Bristol, Oxford, Leeds, and Manchester. It’s exciting to see such advancements in NHS genomics, as the goal is to integrate this testing into routine patient care. Imagine the relief for families when they don’t have to wait weeks for answers anymore!
So, what’s next? As the NHS continues to innovate and improve patient care, it’s clear that the future of brain tumour diagnosis is looking brighter than ever. Will more rapid tests emerge in other areas of medicine? Only time will tell…
Kaynak: Orijinal Haber